MMP9 and early-onset autosomal dominant Alzheimer disease: MMP‐9 is associated with ECM remodeling and discriminates well between patients with vascular cognitive impairment and Alzheimer's disease,5 but it is possible that measurement in the serum is not sensitive enough to capture a treatment effect.